Skin Infections (Topical)

Nutraseb Available for the Management of Seborrheic Dermatitis

By August 15, 2017

A clinical trial of Promiseb (NCT01214434) found the cream to be safe and significantly efficacious in reducing scaling from baseline to end of treatment when compared with a bland emollient (58%; SD: 62 vs. 90%; SD: 22).

Tegaderm CHG IV Securement Dressing Reduces Catheter-Related Infections

By June 06, 2017

In the clinical trial, upon catheter removal, there were decreases noted in catheter colonization and skin colonization rates.

Vibativ Efficacy Against Difficult-to-Treat Bacteria Compared with Other Antibiotics

By April 25, 2017

The favorable in vivo results further confirm the ongoing use of Vibativ for its use in HABP/VABP due to S. aureus, including MRSA.

FDA: Final Ruling on OTC Antibacterial Soaps

By September 02, 2016

The Food and Drug Administration (FDA) issued a final rule regarding over-the-counter (OTC) consumer antiseptic wash products containing certain active ingredients.

FDA to Review New Generation Topical Quinolone for Impetigo

By August 31, 2016

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ozenoxacin 1% cream (Medimetriks) for the treatment of impetigo.

Do Nonsterile Gloves Up the Risk of Infection in Minor Skin Surgery?

August 05, 2016

Meta-analysis shows no increased relative risk for wound infections in outpatient cutaneous surgery

Recall Initiated for Antibacterial Cream, Ointments

By July 22, 2016

GlaxoSmithKline announced a recall of 13 lots of Bactroban (mupirocin) Nasal Ointment, Bactroban Ointment, and Bactroban Cream. This recall is a precautionary measure due to potential contamination during manufacturing.

FDA to Review Novel Topical Antibiotic for Impetigo

By June 27, 2016

Ozenoxacin belongs to a novel generation of non-fluorinated quinolones

Skin Infection Patients Adhere to Just Over Half of Their Antibiotic Regimen, Study Finds

By March 28, 2016

Patients with Staphylococcus aureus skin and soft tissue infections took an average of 57% of their antibiotic doses after being discharged from the hospital, a new study published in Antimicrobial Agents and Chemotherapy reported.

Glenmark Approved for Generic Lotrisone Cream

By February 09, 2016

Glenmark has granted final approval from the Food and Drug Administration (FDA) for Clotrimazole and Betamethasone Dipropionate Cream, the generic version of Merck's Lotrisone Cream.

The Most Common Dermatological Adverse Events After Acupuncture

September 10, 2015

Various dermatological adverse events may occur after acupuncture, with the most common adverse event being infectious skin disease.

Cellulitis Often Misdiagnosed in Inpatient Setting

June 25, 2015

Cellulitis is frequently misdiagnosed in the inpatient setting, according to research published in the Journal of the American Academy of Dermatology.

Which Tattoo Ink Colors Are Most Likely to Cause Skin Reactions?

By May 28, 2015

Researchers at the NYU Langone Medical Center have reported that up to six percent of adults in New York who get tattoos have experienced some form of tattoo-related rash, severe itching, or swelling that lasted from four months up to years for some.

Comparing Topical Antifungals for Seborrheic Dermatitis

May 08, 2015

A review in the Cochrane Library reviewed existing data from randomized controlled trials on the use of topical antifungals for seborrheic dermatitis in adolescents and adults, with primary outcome measures of complete clearance of symptoms.

Two Older Antibiotics Effective Against Community-Acquired MRSA, Says New Research

By March 19, 2015

Two common antibiotics have been shown to be equally effective in treating uncomplicated community-acquired skin infections like methicillin-resistant Staphylococcus aureus (MRSA), according to a new study in the New England Journal of Medicine.

Rapid-Onset Bacterial Infection Reported After Laser Treatment

March 18, 2015

Report describes five cases of rapid-onset bacterial infection occurring one day to one week after tx

Satellite Lesions Prognostic for High-Risk Herpes Zoster

January 09, 2015

Presence of satellite lesions linked to increased risk of severe, multidermatome, multistage disease

Naftin Gel, Cream 2% Approved for Pediatric Use

December 08, 2014

Merz Dermatology announced that Naftin (naftifine HCl) Gel 2% and Naftin (naftifine HCl) Cream 2% have been approved for the treatment of interdigital type tinea pedis in pediatric patients aged 12-17 years.

Bacterial Pathogens Identified in HS Lesions

November 21, 2014

Bacteria that are known to cause soft tissue and skin infections have been found in association with hidradenitis suppurativa (HS) lesions.

Amneal Launches Four New Generic Products

August 13, 2014

Amneal announced the launch of four new generic medications: Acyclovir Ointment, Atovaquone Oral Suspension, Clindamycin Palmitate HCl for Oral Solution (Pediatric), and Oxycodone HCl Tablets.

FDA Warns of Infection Risk in Home Tattoo Kits

August 08, 2014

Inks in some home tattoo kits are contaminated and could cause skin infections.

Reducing Surgical Site Infections Could Lower Costs

May 27, 2014

Surgical site infections are associated with significant excess costs, with deep surgical site infections and those in neurosurgery patients have highest costs.

Sutures Superior to Staples for C-Section Closure

May 12, 2014

Compared with staple closure, suture closure of the skin after cesarean delivery is associated with a reduced incidence of wound complications.

New Fast-Acting Antifungal Cream Launched

April 11, 2014

Valeant announced that Luzu (luliconazole) Cream is now available.

Teledermatology Is Reliable for Initial Triage Consultations

February 18, 2014

Teledermatology is reliable for initial triage of patients, according to a study published online.

AAD Issues Top Five <i>Choosing Wisely</i> Recommendations

November 27, 2013

The top five dermatology-related issues that physicians and patients should question have been released by the American Academy of Dermatology (AAD) as part of the Choosing Wisely campaign.

Interim Overall Survival Results Announced for T-VEC in Melanoma Study

November 18, 2013

Amgen announced interim overall survival (OS) results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC, or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).

Luzu Cream Approved for Skin Fungal Infections

November 15, 2013

Valeant announced that the New Drug Application for Luzu (luliconazole) Cream, 1% has been approved by the FDA.

FDA Addresses Improper OTC Topical Antiseptic Use

November 13, 2013

The FDA is requesting label and packaging changes to improve the safety of certain over-the-counter (OTC) topical antiseptic products.